Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs

Fil: Kurbatova, E V. Centers for Disease Control and Prevention, Atlanta, Georgia; Estados Unidos.

Bibliographic Details
Authors: Kurbatova, E V, Cavanaugh, J S, Shah, N S, Wright, A., Kim, HeeJin, Metchock, B, Van Deun, A., Barrera, Lucía, Boulahbal, F, Richter, E, Martín-Casabona, N, Arias, F, Zemanova, I, Drobniewski, F, Santos Silva, A, Coulter, C, Lumb, R, Cegielski, J P
Format: article
Status:Published version
Publication Date:2012
Country:Argentina
Institution:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
Repository:Sistema de Gestión del Conocimiento ANLIS MALBRÁN
Language:English
OAI Identifier:oai:sgc.anlis.gob.ar:Publications/123456789/2220
Online Access:http://sgc.anlis.gob.ar/handle/123456789/2220
Access Level:Open access
Keyword:Mycobacterium tuberculosis
Tuberculosis
Resistencia a Medicamentos
id AR_183d916107f65be51c19278076a577bb
oai_identifier_str oai:sgc.anlis.gob.ar:Publications/123456789/2220
network_acronym_str AR
network_name_str Argentina
repository_id_str
spelling Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugsKurbatova, E VCavanaugh, J SShah, N SWright, A.Kim, HeeJinMetchock, BVan Deun, A.Barrera, LucíaBoulahbal, FRichter, EMartín-Casabona, NArias, FZemanova, IDrobniewski, FSantos Silva, ACoulter, CLumb, RCegielski, J PMycobacterium tuberculosisTuberculosisResistencia a MedicamentosFil: Kurbatova, E V. Centers for Disease Control and Prevention, Atlanta, Georgia; Estados Unidos.Fil: Cavanaugh, J S. Centers for Disease Control and Prevention, Atlanta, Georgia; Estados Unidos.Fil: Shah, N S. Division of General Internal Medicine, Albert Einstein College of Medicine, Bronx, New York; Estados Unidos.Fil: Wright, A. World Health Organization, Geneva; Suiza.Fil: Kim, HeeJin. Korean Institute of Tuberculosis, Seoul; Korea.Fil: Metchock, B. Centers for Disease Control and Prevention, Atlanta, Georgia; Estados Unidos.Fil: Van Deun, A. Institute of Tropical Medicine, Antwerp; Belgica.Fil: Barrera, Lucia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Boulahbal, F. Institut Pasteur d’Algérie, Alger; Argelia.Fil: Richter, E. National Reference Center for Mycobacteria, Borstel; Alemania.Fil: Martín-Casabona, N. Hospital Universitaris Vall d’Hebron, Barcelona; España.Fil: Arias, F. Institute of Public Health of Chile, Providencia Santiago, Santiago; Chile.Fil: Zemanova, I. National Institute of Public Health, Scrobarova; Chequia.Fil: Drobniewski, F. Health Protection Agency, London; Reino Unido.Fil: Santos Silva, A. National Institute of Health, Porto; Portugal.Fil: Coulter, C. Queensland Mycobacterium Reference Laboratory, Brisbane, Queensland; Australia.Fil: Lumb, R. Institute of Medical and Veterinary Science, Adelaide, South Australia; Australia.Fil: Cegielski, J P. Centers for Disease Control and Prevention, Atlanta, Georgia; Estados Unidos.Based on data from 14 Supranational Tuberculosis (TB) Reference Laboratories worldwide, the proportion of rifampicin (RMP) resistant isolates that were isoniazid (INH) susceptible by phenotypic drug susceptibility testing varied widely (0.5-11.6%). RMP-resistant isolates that were INH-susceptible had significantly lower rates of resistance to other first- and second-line anti-tuberculosis drugs (except rifabutin) compared to multidrug-resistant isolates. RMP resistance is not always a good proxy for a presumptive diagnosis of multidrug-resistant TB, which has implications for use of molecular assays that identify only RMP resistance-associated DNA mutations.International Union Against Tuberculosis and Lung Disease2012info:ar-repo/semantics/articuloinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdf1815-7920http://sgc.anlis.gob.ar/handle/123456789/222010.5588/ijtld.11.0542International Journal of Tuberculosis and Lung Disease 2012 ;16(3):355-7.reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁNinstname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"instacron:ANLISThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Diseaseenginfo:eu-repo/semantics/openAccess2024-05-10T11:52:26Zoai:sgc.anlis.gob.ar:Publications/123456789/2220Institucionalhttp://sgc.anlis.gob.ar/Organismo científico-tecnológicoNo correspondehttp://sgc.anlis.gob.ar/oai/biblioteca@anlis.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:a2024-05-10 11:52:27.465Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"false
dc.title.none.fl_str_mv Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs
title Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs
spellingShingle Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs
Kurbatova, E V
Mycobacterium tuberculosis
Tuberculosis
Resistencia a Medicamentos
title_short Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs
title_full Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs
title_fullStr Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs
title_full_unstemmed Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs
title_sort Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs
dc.creator.none.fl_str_mv Kurbatova, E V
Cavanaugh, J S
Shah, N S
Wright, A.
Kim, HeeJin
Metchock, B
Van Deun, A.
Barrera, Lucía
Boulahbal, F
Richter, E
Martín-Casabona, N
Arias, F
Zemanova, I
Drobniewski, F
Santos Silva, A
Coulter, C
Lumb, R
Cegielski, J P
author Kurbatova, E V
author_facet Kurbatova, E V
Cavanaugh, J S
Shah, N S
Wright, A.
Kim, HeeJin
Metchock, B
Van Deun, A.
Barrera, Lucía
Boulahbal, F
Richter, E
Martín-Casabona, N
Arias, F
Zemanova, I
Drobniewski, F
Santos Silva, A
Coulter, C
Lumb, R
Cegielski, J P
author_role author
author2 Cavanaugh, J S
Shah, N S
Wright, A.
Kim, HeeJin
Metchock, B
Van Deun, A.
Barrera, Lucía
Boulahbal, F
Richter, E
Martín-Casabona, N
Arias, F
Zemanova, I
Drobniewski, F
Santos Silva, A
Coulter, C
Lumb, R
Cegielski, J P
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Mycobacterium tuberculosis
Tuberculosis
Resistencia a Medicamentos
topic Mycobacterium tuberculosis
Tuberculosis
Resistencia a Medicamentos
description Fil: Kurbatova, E V. Centers for Disease Control and Prevention, Atlanta, Georgia; Estados Unidos.
publishDate 2012
dc.date.none.fl_str_mv 2012
dc.type.none.fl_str_mv info:ar-repo/semantics/articulo
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv 1815-7920
http://sgc.anlis.gob.ar/handle/123456789/2220
10.5588/ijtld.11.0542
identifier_str_mv 1815-7920
10.5588/ijtld.11.0542
url http://sgc.anlis.gob.ar/handle/123456789/2220
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv International Union Against Tuberculosis and Lung Disease
publisher.none.fl_str_mv International Union Against Tuberculosis and Lung Disease
dc.source.none.fl_str_mv International Journal of Tuberculosis and Lung Disease 2012 ;16(3):355-7.
reponame:Sistema de Gestión del Conocimiento ANLIS MALBRÁN
instname:Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
instacron:ANLIS
instname_str Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
instacron_str ANLIS
institution ANLIS
reponame_str Sistema de Gestión del Conocimiento ANLIS MALBRÁN
collection Sistema de Gestión del Conocimiento ANLIS MALBRÁN
repository.name.fl_str_mv Sistema de Gestión del Conocimiento ANLIS MALBRÁN - Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
repository.mail.fl_str_mv biblioteca@anlis.gov.ar
_version_ 1799196868818763776
score 15,812455

Similar Items